LIPELLA PHARMACEUTICALS INC (LIPO) Stock Balance Sheet
NASDAQ:LIPO - Nasdaq - US53630L2097 - Common Stock - Currency: USD
| MRQ (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 1.19M | 3.29M | 5.12M | 1.41M | 606.74K | |||
| Marketable Securities | N/A | N/A | 0.00 | 300.55K | 0.00 | |||
| Receivables | 35.33K | 32.29K | 113.66K | 0.00 | 69.04K | |||
| Other Current Assets | 858.99K | 103.26K | 563.89K | 93.72K | 23.66K | |||
| Total Current Assets | 2.08M | 3.43M | 5.80M | 1.81M | 699.43K | |||
| Non-Current Assets | ||||||||
| PPE Net | 103.29K | 147.89K | 150.82K | 204.80K | 255.59K | |||
| Total Non-Current Assets | 103.28K | 147.89K | 150.82K | 204.80K | 255.59K | |||
| TOTAL ASSETS | 2.18M | 3.58M | 5.95M | 2.01M | 955.02K | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 57.04K | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 275.00K | 25.00K | 25.00K | |||
| Accrued Expenses | 301.95K | 247.34K | 518.90K | 268.73K | 101.19K | |||
| Accounts Payable | 178.36K | 138.02K | 384.36K | 46.90K | 24.54K | |||
| Total Current Liabilities | 480.31K | 385.36K | 1.18M | 340.63K | 207.77K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 50.00K | 50.00K | |||
| Other Non-Current Liabilities | 0.00 | 47.37K | 96.26K | 198.71K | 233.94K | |||
| Total Non-Current Liabilities | 0.00 | 47.37K | 96.25K | 248.71K | 283.93K | |||
| TOTAL LIABILITIES | 480.31K | 432.73K | 1.27M | 589.34K | 491.70K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -12.45M | -10.32M | -5.70M | -3.11M | -1.24M | |||
| Additional Paid In Capital | 14.16M | 13.47M | 10.38M | 4.53M | 1.70M | |||
| Common Shares | 760.00 | 610.00 | 570.00 | 1.13K | 730.00 | |||
| Shares Outstanding | 950.70K | 756.74K | 717.99K | 717.99K | 5.74M | |||
| Tangible Book Value per Share | 1.79 | 4.16 | 6.51 | 1.98 | 0.08 | |||
| Total Shareholders' Equity | 1.70M | 3.14M | 4.68M | 1.42M | 463.32K | |||
| TOTAL LIABILITIES AND EQUITY | 2.18M | 3.58M | 5.95M | 2.01M | 955.02K | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.04 | 0.23 | |||
| Current Ratio | 4.33 | 8.90 | 4.92 | 5.31 | 3.37 | |||
| Return On Assets (ROA) | -189.66% | -129.12% | -43.66% | -92.68% | -6.46% | |||
| Return On Equity (ROE) | -243.13% | -146.89% | -55.56% | -131.04% | -13.31% | |||
All data in USD , ROIC based on taxRate of 0.21